MA01.05 Tislelizumab Plus Chemotherapy Followed by Surgery or Radiotherapy and Adjuvant Tislelizumab in Unresectable Stage III NSCLC

作者：Jia Liu, Lin Tu, Yuan Li, Yuan Li, Li Z, Tianren Wang, Tianren Wang, Qiong Wu, Li Wang, X. Zhai, Jianwei Dong, Meng Fan, Panwen Tian, Dan Pu, Y. Zhang, Feng Luo, Ying Liu, Jing Wang, Fangping Xu, Yongrong Lai, Kai Wang, Xiangyi Zheng, Guowei Che · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.09.100 · 被引用次数：2 · 研究领域：Multiple and Secondary Primary Cancers、Lymphoma Diagnosis and Treatment、Lung Cancer Treatments and Mutations